Julie K. Jadlowsky

CRISPR-engineered T cells in patients with refractory cancer

Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis et al. · Science · 2020 · 1.4K citations · Full text

Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2

Nicholas Funderburg, Michael M. Lederman, Zhimin Feng et al. · Proceedings of the National Academy of Sciences · 2007 · 354 citations · Full text

Adaptive Immune System, Innate Immune System, Immunology +18

Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

Stephen Bagley, Meghan Logun, Joseph A. Fraietta et al. · Nature Medicine · 2024 · 281 citations

Cancer Immunosurveillance, Glioma, Immunology +9

Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients

Katherine T. Marcucci, Julie K. Jadlowsky, Wei‐Ting Hwang et al. · Molecular Therapy · 2017 · 134 citations · Full text

BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion

In-Young Jung, Vivek Narayan, Sierra McDonald et al. · Science Translational Medicine · 2022 · 120 citations · Full text